Recent studies have suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of heart rate-corrected QT interval prolongation and atrial fibrillation in patients with type 2 diabetes. Currently, no data exist regarding the relationship between NAFLD and ventricular arrhythmias in this patient population.

Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring

Mantovani, Alessandro;Rigamonti, Antonio;Bolzan, Bruna;PERNIGO, MATTEO;BERGAMINI, Corinna;RIGOLON, RICCARDO;PICHIRI, Isabella;ZOPPINI, Giacomo;BONORA, Enzo;TARGHER, Giovanni
2016-01-01

Abstract

Recent studies have suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of heart rate-corrected QT interval prolongation and atrial fibrillation in patients with type 2 diabetes. Currently, no data exist regarding the relationship between NAFLD and ventricular arrhythmias in this patient population.
2016
NAFLD, arrhyhmias, type 2 diabetes, 24-h Holter
File in questo prodotto:
File Dimensione Formato  
NAFLD_Arrhythmias_Diabetes Care 2016.pdf

accesso aperto

Tipologia: Documento in Pre-print
Licenza: Accesso ristretto
Dimensione 984.76 kB
Formato Adobe PDF
984.76 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/946250
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 94
  • ???jsp.display-item.citation.isi??? 83
social impact